Regulation of cell proliferation and transdifferentiation compensates for ventilator-induced lung injury mediated by NLRP3 inflammasome activation

被引:2
|
作者
Liu, Huan [1 ]
Yang, Xuepeng [2 ]
Liu, Ge [3 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Anesthesiol, Jinan, Peoples R China
[2] Jinan Second Peoples Hosp, Dept Ophthalmol, Jinan, Peoples R China
[3] Shandong Univ, Qilu Hosp, Dept Ophtalmol, Jinan, Peoples R China
基金
中国国家自然科学基金;
关键词
cell proliferation; NLRP3; inflammasome; transdifferentiation; VILI; REACTIVE ARTHRITIS; POLYARTHRITIS;
D O I
10.1002/iid3.1062
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundMechanical ventilation is an important means of respiratory support and treatment for various diseases. However, its use can lead to serious complications, especially ventilator-induced lung injury (VILI). The mechanisms underlying this disease are complex, but activation of inflammatory signalling pathways results in activation of cytokines and inflammatory mediators, which play key roles in VILI. Recent studies have demonstrated that nod-like receptor protein 3 (NLRP3) inflammasome activation mediates VILI and also accompanied by cell proliferation and transdifferentiation to compensate for alveolar membrane damage. Type I alveolar epithelial cells (AECs I), which are involved in the formation of the blood-air barrier, are vulnerable to damage but cannot proliferate by themselves; thus, replacing AECs I relies on type II alveolar epithelial cells (AECs II).ObjectiveThe review aims to introduce the mechanisms of NLRP3 inflammasome activation and its inhibitors, as well as the mechanisms that regulate cell proliferation and transdifferentiation.MethodsA large number of relevant literature was searched, then the key content was summarized and figures were also made.ResultsThe mechanism of NLRP3 inflammasome activation has been further explored, including but not limited to pathogenic and aseptic inflammatory signals, such as, pathogenic molecular patterns and host-derived danger-associated molecular patterns activate toll-like receptor 4/nuclear factor-kappaB pathway or reactive oxygen species, cyclic stretch, adenosine triphosphate induce K+ efflux through P2X7, Ca2+ inflow, mitochondrial damage, etc, eventually induce NIMA-related kinase 7/NLRP3 binding and NLRP3 inflammasome activation. Not only that, the review also described in detail the inhibitors of NLRP3 inflammasome. And the mechanisms regulating cell proliferation and transdifferentiation are complex and unclear, including the Wnt/beta-catenin, Yap/Taz, BMP/Smad and Notch signalling pathways.ConclusionsNLRP3 inflammasome activation mediated VILI, and VILI is alleviated after interfering with its activation, and inflammation and repair exist simultaneously in VILI. Clarifying these mechanisms is expected to provide theoretical guidance for alleviating VILI by inhibiting the inflammatory response and accelerating alveolar epithelial cell regeneration in the early stage. Nod-like receptor protein 3 inflammasome activation induces ventilator-induced lung injury (VILI). But, the inflammatory process of VILI is accompanied by the proliferation and transdifferentiation of alveolar epithelial cells, the significance of this phenomenon is to inhibit the occurrence of VILI in the early stage by compensating for the inflammatory response via repairing damaged alveolar membranes.image
引用
收藏
页数:11
相关论文
共 50 条
  • [41] The Effects of Morin on Lipopolysaccharide-Induced Acute Lung Injury by Suppressing the Lung NLRP3 Inflammasome
    Zhang Tianzhu
    Yang Shihai
    Du Juan
    INFLAMMATION, 2014, 37 (06) : 1976 - 1983
  • [42] Inhibition of NLRP3 inflammasome attenuates spinal cord injury-induced lung injury in mice
    Jiang, Wu
    Li, Maoqiang
    He, Fan
    Zhu, Liulong
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (05) : 6012 - 6022
  • [43] Dynasore Alleviates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis
    Shan, Mengtian
    Wan, Huimin
    Ran, Linyu
    Ye, Jihui
    Xie, Wang
    Lu, Jingjing
    Hu, Xueping
    Deng, Shengjie
    Zhang, Wenyu
    Chen, Miao
    Wang, Feilong
    Guo, Zhongliang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 1369 - 1384
  • [44] Role of NLRP3 inflammasome activation in HCC cell progression
    Dai, Bingling
    Cao, Hanbing
    Hu, Yu
    Gong, Zhengyan
    Huang, Xiaoyue
    Chen, Yanbin
    Liu, Feng
    Peng, Xiujuan
    Zhang, Yanmin
    Lei, Xinjun
    HELIYON, 2023, 9 (09)
  • [45] The Protective Effects of Vanillic Acid on LPS-induced Acute Lung Injury by Inhibiting STIM1-mediated NLRP3 Inflammasome Activation
    Wang, Lei
    Li, Hai-dong
    Sun, Xia
    Ni, Jia-hui
    Feng, Gui-ze
    Shen, Xiao-yan
    Weng, Hong-bo
    Fang, Hao
    INFLAMMATION, 2025,
  • [46] Fibroblast growth factor 21 attenuates ventilator-induced lung injury by inhibiting the NLRP3/caspase-1/GSDMD pyroptotic pathway
    Ding, Peng
    Yang, Rui
    Li, Cheng
    Fu, Hai-Long
    Ren, Guang-Li
    Wang, Pei
    Zheng, Dong-Yu
    Chen, Wei
    Yang, Li-Ye
    Mao, Yan-Fei
    Yuan, Hong-Bin
    Li, Yong-Hua
    CRITICAL CARE, 2023, 27 (01)
  • [47] Regulation of the NLRP3 inflammasome with natural products against chemical-induced liver injury
    Zou, Jian
    Wang, Sheng-Peng
    Wang, Yi-Tao
    Wan, Jian-Bo
    PHARMACOLOGICAL RESEARCH, 2021, 164
  • [48] Loganin reduces diabetic kidney injury by inhibiting the activation of NLRP3 inflammasome-mediated pyroptosis
    Kong, Xiangri
    Zhao, Yunyun
    Wang, Xingye
    Yu, Yongjiang
    Meng, Ying
    Yan, Guanchi
    Yu, Miao
    Jiang, Lihong
    Song, Wu
    Wang, Bingmei
    Wang, Xiuge
    CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 382
  • [49] PRAVASTATIN ENHANCES THE NLRP3 INFLAMMASOME ACTIVATION AND DETERIORATES BLEOMYCIN INDUCED LUNG INFLAMMATION AND FIBROSIS
    Xu, J-F
    Nakahira, K.
    Lee, S-J
    Patel, A. S.
    Li, H-P
    Qu, J-M
    Morse, D.
    Ryter, S. W.
    Choi, A. M. K.
    RESPIROLOGY, 2011, 16 : 314 - 314
  • [50] Insight into the regulation of NLRP3 inflammasome activation by mitochondria in liver injury and the protective role of natural products
    Liu, Yu
    Guo, Zi-wei
    Li, Jian
    Li, Ai-hong
    Huo, Tao-guang
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 156